Cargando…
Identification of hematein as a novel inhibitor of protein kinase CK2 from a natural product library
BACKGROUND: Casein kinase 2 (CK2) is dysregulated in various human cancers and is a promising target for cancer therapy. To date, there is no small molecular CK2 inhibitor in clinical trial yet. With the aim to identify novel CK2 inhibitors, we screened a natural product library. METHODS: We adopted...
Autores principales: | Hung, Ming-Szu, Xu, Zhidong, Lin, Yu-Ching, Mao, Jian-Hua, Yang, Cheng-Ta, Chang, Pey-Jium, Jablons, David M, You, Liang |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2696466/ https://www.ncbi.nlm.nih.gov/pubmed/19419583 http://dx.doi.org/10.1186/1471-2407-9-135 |
Ejemplares similares
-
Hematein, a casein kinase II inhibitor, inhibits lung cancer tumor growth in a murine xenograft model
por: HUNG, MING-SZU, et al.
Publicado: (2013) -
Coumestrol from the national cancer Institute’s natural product library is a novel inhibitor of protein kinase CK2
por: Liu, Shu, et al.
Publicado: (2013) -
Functional Polymorphism of the CK2α Intronless Gene Plays Oncogenic Roles in Lung Cancer
por: Hung, Ming-Szu, et al.
Publicado: (2010) -
Identification of a Potent Allosteric Inhibitor of Human Protein Kinase CK2 by Bacterial Surface Display Library Screening
por: Nienberg, Christian, et al.
Publicado: (2017) -
Effects of okadaic acid and hematein on human lung adenocarcinoma A549 cells and responses of mitochondria and endoplasmic reticulum apoptosis pathways
por: Wang, Renjun, et al.
Publicado: (2019)